Latest news
BlossomHill Therapeutics (BLSM): IPO Falls Flat After Aggressive Upsizing - SmartkarmaSmartkarma · Sat, 08 Aug 2026 02:04:27 GMTLatham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO - Latham & Watkins LLPLatham & Watkins LLP · Fri, 07 Aug 2026 20:38:12 GMTBlossomHill Therapeutics shares fall in debut after IPO - Investing.comInvesting.com · Fri, 07 Aug 2026 20:34:34 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTBlossomHill Therapeutics Shares Fall in Nasdaq Debut - MoomooMoomoo · Fri, 07 Aug 2026 19:11:07 GMTLatigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 17:52:10 GMTCancer drug developer BlossomHill slips post IPO (BLSM:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:40:23 GMTUS Stocks Movement | BlossomHill Therapeutics (BLSM.US) Listed on US Stock Market, Shares Slightly Declined After Opening - BitgetBitget · Fri, 07 Aug 2026 17:21:45 GMT